Sign in
bf/NASDAQ:EOLS_icon.jpeg

NASDAQ:EOLS

Evolus, Inc.

  • Stock

USD

Last Close

12.13

26/07 20:00

Market Cap

685.58M

Beta: 1.83

Volume Today

222.90K

Avg: 456.99K

PE Ratio

−11.60

PFCF: −4.70

OverviewFinancialsFilingspeopleOwnershipAPIChartData

  • locale

    usUnited States

  • market

    STOCKS

  • industry

    Drug Manufacturers - Specialty & Generic

  • website

    www.evolus.com

  • ipo date

    Feb 08, 2018

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquarter...Show More

Excel Tearsheet

peer of

Earnings

Earnings Release in 4 days

Earnings per Share (Estimate*)

-1-0.52016-12-312018-05-102019-11-042021-05-122022-11-082024-05-07

Revenue (Estimate*)

10M20M30M40M50M60M2016-12-312018-05-102019-11-042021-05-122022-11-082024-05-07

*Estimate based on analyst consensus